Literature DB >> 15783019

Effect of the herbal medicine Dai-kenchu-to for serum ammonia in hepatectomized patients.

Takashi Kaiho1, Toshikazu Tanaka, Shunichi Tsuchiya, Shnji Yanagisawa, Osamu Takeuchi, Masami Miura, Naoki Saigusa, Masaru Miyazaki.   

Abstract

BACKGROUND/AIMS: Prolonged paralytic ileus occurring in hepatectomized patients may induce hyperammonemia or bacterial translocation, which injures the remnant liver function and sometimes causes post-resection liver failure. We examined the effectiveness of the herbal medicine, Dai-kenchu-to (DKT), on postoperative serum ammonia levels in patients with liver resection and compared it with lactulose.
METHODOLOGY: Patients with liver resection were divided into three groups. Lactulose group (n=31), 16g of lactulose was administered orally three times a day from the first postoperative day. DKT group (n=27), 5g of DKT was administered in the same fashion. Control group (n=26), neither lactulose nor DKT was administered. In all three groups, 16g of lactulose was administered three times a day for three days preoperatively.
RESULTS: There was no significant difference among the groups in age, gender and preoperative hepatic functional values, such as ICG-R15 or galactose tolerance test. There was also no difference in parenchymal hepatic resection rate, operative time and amount of intraoperative bleeding volume. Postoperative serum ammonia levels were significantly lower in the DKT group than control and lactulose groups. Instances of delayed flatulence and occurrence of diarrhea were also fewer in the DKT group.
CONCLUSIONS: DKT may become a more effective and safe agent than lactulose in postoperative management of liver resection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15783019

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  10 in total

Review 1.  Surrogate endpoints in liver surgery related trials: a systematic review of the literature.

Authors:  Liliane Mpabanzi; Kim M C van Mierlo; Massimo Malagó; Cornelis H C Dejong; Dimitrios Lytras; Steven W M Olde Damink
Journal:  HPB (Oxford)       Date:  2012-10-22       Impact factor: 3.647

2.  Effect of Daikenchuto (TJ-100) on abdominal bloating in hepatectomized patients.

Authors:  Kazuhiro Hanazaki; Kengo Ichikawa; Masaya Munekage; Hiroyuki Kitagawa; Ken Dabanaka; Tsutomu Namikawa
Journal:  World J Gastrointest Surg       Date:  2013-04-27

3.  The effects of the Kampo medicine (Japanese herbal medicine) "Daikenchuto" on the surgical inflammatory response following laparoscopic colorectal resection.

Authors:  Kozo Yoshikawa; Mitsuo Shimada; Masanori Nishioka; Nobuhiro Kurita; Takashi Iwata; Shinya Morimoto; Tomohiko Miyatani; Masato Komatsu; Hideya Kashihara; Chie Mikami
Journal:  Surg Today       Date:  2011-12-28       Impact factor: 2.549

4.  Kampo medicine "Dai-kenchu-to" prevents bacterial translocation in rats.

Authors:  Kozo Yoshikawa; Nobuhiro Kurita; Jun Higashijima; Tomohiko Miyatani; Hidenori Miyamoto; Masanori Nishioka; Mitsuo Shimada
Journal:  Dig Dis Sci       Date:  2008-04-30       Impact factor: 3.199

5.  Effect of TU-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer: a multi-center, phase III trial (JFMC40-1001).

Authors:  Mitsuo Shimada; Yuji Morine; Hiroaki Nagano; Etsuro Hatano; Takashi Kaiho; Masaru Miyazaki; Toru Kono; Toshiya Kamiyama; Satoshi Morita; Junichi Sakamoto; Mitsuo Kusano; Shigetoyo Saji; Takashi Kanematsu; Masaki Kitajima
Journal:  Int J Clin Oncol       Date:  2014-03-06       Impact factor: 3.402

6.  Inchingorei-san (TJ-117) and Artemisiae Capillaris Herba Induced Prolonged Survival of Fully Mismatched Cardiac Allografts and Generated Regulatory Cells in Mice.

Authors:  Xiangyuan Jin; Masateru Uchiyama; Qi Zhang; Toshihito Hirai; Masanori Niimi
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-02       Impact factor: 2.629

Review 7.  Kampo medicines for gastrointestinal tract disorders: a review of basic science and clinical evidence and their future application.

Authors:  Kazunari Tominaga; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2013-03-16       Impact factor: 7.527

Review 8.  Daikenchuto for reducing postoperative ileus in patients undergoing elective abdominal surgery.

Authors:  Nobuaki Hoshino; Toshihiko Takada; Koya Hida; Suguru Hasegawa; Toshi A Furukawa; Yoshiharu Sakai
Journal:  Cochrane Database Syst Rev       Date:  2018-04-05

9.  Efficiency of herbal medicine Dai-kenchu-to on portal blood flow in rat models.

Authors:  Izumi Muraoka; Mitsuhisa Takatsuki; Akihiko Soyama; Izumi Yamaguchi; Shiro Tanaka; Takayuki Tanaka; Ayaka Kinoshita; Takanobu Hara; Tamotsu Kuroki; Susumu Eguchi
Journal:  Ann Med Surg (Lond)       Date:  2015-05-30

10.  Daikenchuto (TU-100) shapes gut microbiota architecture and increases the production of ginsenoside metabolite compound K.

Authors:  Takumu Hasebe; Nobuhiro Ueno; Mark W Musch; Anuradha Nadimpalli; Atsushi Kaneko; Noriko Kaifuchi; Junko Watanabe; Masahiro Yamamoto; Toru Kono; Yuhei Inaba; Mikihiro Fujiya; Yutaka Kohgo; Eugene B Chang
Journal:  Pharmacol Res Perspect       Date:  2016-02-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.